<DOC>
<DOCNO>
EP-0003750
</DOCNO>
<TEXT>
<DATE>
19790905
</DATE>
<IPC-CLASSIFICATIONS>
C07C-313/00 A61K-31/185 A61K-31/675 C07C-67/00 <main>A61K-31/66</main> A61P-35/00 
</IPC-CLASSIFICATIONS>
<TITLE>
salts of dithiodialkanesulfonic acids for use in cytostatic therapy with alkylating agents.
</TITLE>
<APPLICANT>
asta werke ag chem fabde<sep>asta-werke aktiengesellschaft chemische fabrik<sep>asta-werke aktiengesellschaft chemische fabrikartur-ladebeck-strasse 128 - 152 postfach 14 01 29d-4800 bielefeld 14de  <sep>asta-werke aktiengesellschaft chemische fabrik <sep>
</APPLICANT>
<INVENTOR>
brock norbert prof dr<sep>stekar jurij dr<sep>brock, norbert, prof. dr.<sep>stekar, jurij, dr.<sep>brock, norbert, prof. dr.am rehhagen 10d-4800 bielefeld 1de<sep>stekar, jurij, dr.asta-strasse 29d-4800 bielefeld 14de<sep>brock, norbert, prof. dr. <sep>stekar, jurij, dr.  <sep>brock, norbert, prof. dr.am rehhagen 10d-4800 bielefeld 1de<sep>stekar, jurij, dr.asta-strasse 29d-4800 bielefeld 14de<sep>
</INVENTOR>
<ABSTRACT>
The invention relates to the novel use of pharmacologically acceptable salts of dithiodialkanesulfonic acids of the general formula in cytostatic therapy with alkylants with the surprising result that the strong irritation caused by alkylants, urinary tracts and bubble, which often require a termination of cytostatic therapy,no longer occur.
</ABSTRACT>
</TEXT>
</DOC>
